_version_ 1782310071633444864
author Kim, Seok Jin
author_facet Kim, Seok Jin
author_sort Kim, Seok Jin
collection PubMed
description
format Online
Article
Text
id pubmed-3974950
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-39749502014-04-10 Mantle cell lymphoma: a model for risk-adapted treatment approach Kim, Seok Jin Blood Res Editorial Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014-03 2014-03-24 /pmc/articles/PMC3974950/ /pubmed/24724057 http://dx.doi.org/10.5045/br.2014.49.1.1 Text en © 2014 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Kim, Seok Jin
Mantle cell lymphoma: a model for risk-adapted treatment approach
title Mantle cell lymphoma: a model for risk-adapted treatment approach
title_full Mantle cell lymphoma: a model for risk-adapted treatment approach
title_fullStr Mantle cell lymphoma: a model for risk-adapted treatment approach
title_full_unstemmed Mantle cell lymphoma: a model for risk-adapted treatment approach
title_short Mantle cell lymphoma: a model for risk-adapted treatment approach
title_sort mantle cell lymphoma: a model for risk-adapted treatment approach
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974950/
https://www.ncbi.nlm.nih.gov/pubmed/24724057
http://dx.doi.org/10.5045/br.2014.49.1.1
work_keys_str_mv AT kimseokjin mantlecelllymphomaamodelforriskadaptedtreatmentapproach